SAR-442085

N/A

Report date: 2024/09/04 20:00:55

Base Information

Drug NameSAR-442085
Drug Alias NameSAR-442085
ClassificationBiologics
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsApoptosis stimulantsPhagocytes stimulants +[4] 
TargetsLymphocyte differentiation antigen CD38
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesTaiwan +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A